Koji Onomoto

Prof. Koji Onomoto


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2018 in Genes
Verified
Journal Article
Open access
PDF file
TTTomoko Takahashi
Tomoko Takahashi
YNYuko Nakano
Yuko Nakano
KOKoji Onomoto
Koji Onomoto
MYMitsutoshi Yoneyama
Mitsutoshi Yoneyama
Kumiko Ui-TeiKumiko Ui-Tei
Kumiko Ui-Tei
Exogenous double-stranded RNAs (dsRNAs) similar to viral RNAs induce antiviral RNA silencing or RNA interference (RNAi) in plants or invertebrates, whereas interferon (IFN) response is induced through activation of virus sensor proteins including Toll like receptor 3 (TLR3) or retinoic acid-inducible gene I (RIG-I) like receptors (RLRs) in mammalian cells. Both RNA silencing and IFN response are triggered by dsRNAs. However, the relationship between these two pathways has remained unclear. Laboratory of genetics and physiology 2 (LGP2) is one of the RLRs, but its function has remained unclear. Recently, we reported that LGP2 regulates endogenous microRNA-mediated RNA silencing by interacting with an RNA silencing enhancer, TAR-RNA binding protein (TRBP). Here, we investigated the contribution of other RLRs, RIG-I and melanoma-differentiation-associated gene 5 (MDA5), in the regulation of RNA silencing. We found that RIG-I, but not MDA5, also represses short hairpin RNA (shRNA)-induced RNAi by type-I IFN. Our finding suggests that RIG-I, but not MDA5, interacts with TRBP indirectly through LGP2 to function as an RNAi modulator in mammalian cells.

1 July 2026 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
YAYuna Aoki
Yuna Aoki
KOKoji Onomoto
Koji Onomoto
KKKa-Ho Kato
Ka-Ho Kato
HIHayato Ishikawa
Hayato Ishikawa
MKMariko Kitajima
Mariko Kitajima
MYMitsutoshi Yoneyama
Mitsutoshi Yoneyama
RNA virus infections pose a serious threat to public health, underscoring the need for broad-spectrum antiviral agents. In this study, we screened 383 plant-derived natural products with distinctive and structurally unique frameworks. We identified three Amaryllidaceae alkaloids, haemanthamine, crinamine, and 6-hydroxycrinamine, that exhibited inhibitory activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Vero E6/TMPRSS2 cells. Notably, these compounds concentration-dependently inhibited the replication of not only SARS-CoV-2 but also encephalomyocarditis virus, Sindbis virus, vesicular stomatitis virus, and influenza A virus, with antiviral activity distinguishable from cytotoxicity. These results suggest that Amaryllidaceae alkaloids possess broad-spectrum antiviral activity and are promising candidates for future antiviral drug development.